These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 5835877
21. [Guanfacine: controlled clinical study in arterial hypertension]. Lauro R. Clin Ter; 1980 May 31; 93(4):439-55. PubMed ID: 6998644 [No Abstract] [Full Text] [Related]
22. [Antihypertensive therapy: campaign of the giants]. Füessl HS. MMW Fortschr Med; 2005 Dec 15; 147(51-52):28. PubMed ID: 16402700 [No Abstract] [Full Text] [Related]
23. [Variability of arterial pressure in arterial hypertension and effects of antihypertensive therapy]. Martynov AI, Ostroumova OD, Mamaev VI, Rybkina TE, Novinskiĭ AA, Mel'nikov OA, Akimov VN. Klin Med (Mosk); 2002 Dec 15; 80(6):4-7. PubMed ID: 12138801 [No Abstract] [Full Text] [Related]
24. The Australian National Blood Pressure Study: a therapeutic trial in mild hypertension. Aust Fam Physician; 1981 Apr 15; 10(4):234, 237-9. PubMed ID: 7018480 [No Abstract] [Full Text] [Related]
25. [Hypertension in the aged]. Furberg CD. Katilolehti; 1981 Jun 15; 86(6):202-6. PubMed ID: 6911325 [No Abstract] [Full Text] [Related]
26. Hypertension control in the United States. Results of a recent study. Levy RI. Przegl Lek; 1981 Jun 15; 38(4):377-83. PubMed ID: 7268036 [No Abstract] [Full Text] [Related]
27. Should calcium channel blockers be used as first-line antihypertensive therapy? Reust CE. J Fam Pract; 2001 Mar 15; 50(3):258. PubMed ID: 11252219 [No Abstract] [Full Text] [Related]
28. [The prognosis of arterial hypertension and its modification by antihypertensive therapy]. Holzgreve H. Internist (Berl); 1981 Mar 15; 22(3):156-61. PubMed ID: 7012081 [No Abstract] [Full Text] [Related]
29. Antihypertensive drug therapy in Saskatchewan. Hollenberg NK. Curr Hypertens Rep; 2002 Jun 15; 4(3):179. PubMed ID: 12058694 [No Abstract] [Full Text] [Related]
30. The 2000 Canadian Hypertension Recommendations: a summary. Canadian Hypertension Recommendations Working Group. Can J Cardiol; 2001 May 15; 17(5):535-8. PubMed ID: 11381276 [No Abstract] [Full Text] [Related]
32. [Perseverance in antihypertensive therapy: comparison of 2 follow-up systems]. Florenzano R, Roessler E, Scharazer J, Soto I, Cantú AM. Bol Oficina Sanit Panam; 1981 Nov 15; 91(5):428-40. PubMed ID: 6459788 [No Abstract] [Full Text] [Related]
33. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments. Simpson FO. J Hypertens; 1997 Jan 15; 15(1):1-2. PubMed ID: 9050964 [No Abstract] [Full Text] [Related]
35. [Clinical observations on the use of an antihypertensive drug (Compound 1003)]. De la Hoz Fabra J, San Millán JG. Rev Clin Esp; 1966 Jan 31; 100(2):126-30. PubMed ID: 5906403 [No Abstract] [Full Text] [Related]